Close Menu

NEW YORK (GenomeWeb) – Vela Diagnostics announced today that its Real-Time PCR-based Sentosa SA ZIKV RT-PCR Test has been approved by the Singapore Health Sciences Authority for in vitro diagnostic use.

The firm's test, which detects Zika in samples with a low viral load, can now be used in Singapore to identify and differentiate Zika in patients suspected to suffer from Zika infections. The test is validated for plasma, serum, and urine samples, alongside patient-matched serum or plasma.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Sep
30
Sponsored by
LGC SeraCare Life Sciences

Non-invasive prenatal testing (NIPT) continues to expand globally to support maternal-fetal patient care. 

Oct
09
Sponsored by
PerkinElmer

As cases of COVID-19 continued to grow this spring and summer in the US, so too did the number of Emergency Use Authorizations from the FDA for clinical diagnostic tests aimed at detecting current and past infections.